Form FDA 766 at a glance
What it is: Form FDA 766 can be used by Industry and FDA field staff when requesting and processing requests to recondition FDA regulated products that have been detained due to a violation of the Act.
Who signs: Signature of applicant requesting the reconditioning proposal.
Page 1 of Form FDA 766, Section 1, is to be completed by the Importer of Record.
A filled-in Form FDA 766 example: an importer applies to relabel goods

How to fill out Form FDA 766, box by box
1. TO, 2. APPLICATION DATE and 3. ENTRY NO. AND LINE NO.

In box 1, TO: Director of Division, enter the name of the Food and Drug Administration Division Office that will be receiving the reconditioning proposal.
In box 2, APPLICATION DATE, enter the date of the proposal in MM/DD/YYYY format.
In box 3, ENTRY NO. AND LINE NO., enter the applicable entry number and line number. Adding the line information is important. Format: 123-4567891-9/11-1.
4. PRODUCT, 5. QUANTITY, 6. QUANTITY TO BE RECONDITIONED and 7. PRODUCTION CODES

In box 4, PRODUCT, enter product name as it appears on the label and brief description of the product.
In box 5, QUANTITY, enter the total quantity of product.
In box 6, QUANTITY TO BE RECONDITIONED, enter the quantity of product to be reconditioned.
In box 7, PRODUCTION CODES, enter the production code or other unique identifiers: Lot numbers, expiration dates, production codes and specific quantities to be reconditioned.
8. Operations location, days to complete and method

For the operations, if authorized, enter in box 8 the name and address of the location where reconditioning operations will take place, including contact information, name and phone number, and the complete name and address of the location.
For the operations, if authorized, enter in box 8 the approximate time (in days) it will take to complete the reconditioning operations.
For the operations, if authorized, enter in box 8 a detailed description of the method by which the merchandise will be brought into compliance.
If additional space is needed, attach the additional documentation to the form. Documentation may include labeling, photographs, private laboratory information.
9. APPLICANT AND FIRM NAME and 10. ADDRESS OF FIRM
SECTION 2 - FDA ACTION ON APPLICATION

SECTION 2 - FDA ACTION ON APPLICATION is to be completed by the FDA Compliance Officer.
In box 14, the “Denied because:” box is marked if the application is denied and the “Approved with the following conditions:” box is marked if the application is approved.
In box 14, the time limit within which the Importer has to complete the authorized reconditioning operations is entered.
SECTION 3 - IMPORTER'S CERTIFICATE

PAGE 2 OF FORM FDA 766: SECTION 3 - IMPORTER'S CERTIFICATE: To be completed by the Importer of Record when the authorized reconditioning operations have been completed.
In box 18, enter the location where the reconditioning operations occurred. This is usually the same location as box 8 on page 1.
In box 19, DATE, enter the date the reconditioning operations were completed in a MM/DD/YYYY format (EX: 11/12/2019).
Box 20a certifies that the work to be performed under the authorization has been completed and the article(s) are now ready for inspection. Enter the location where the reconditioned goods are ready for inspection if different than location specified in box 18. In box 20b, enter the contact information for the location where goods are ready for inspection.
In box 21, enter the location, if necessary, where the rejected portions are held if different than the location specified in box 20 (If different than location where goods are ready for inspection).
In box 22, APPLICANT AND FIRM NAME, enter name of applicant/importer that is certifying reconditioning operations were performed as authorized. Box 23, APPLICANT'S SIGNATURE, is the signature of applicant/importer.
More rules for Form FDA 766
It is no longer necessary to submit the form in triplicate.
Sources
[1] Form FDA 766 (05/24), Application for Authorization to Relabel or Recondition Non-Compliant Articles, U.S. Food and Drug Administration (the Official source link on this page).

